Register Login

NEURONETICS, INC. (STIM)

SymbolSTIM
NameNEURONETICS, INC.
SectorHEALTH CARE
RegionNorth America
IndustryMedical/Dental Instruments
Address3222 PHOENIXVILLE PIKE, MALVERN, Pennsylvania, 19355, United States
Telephone+1 610 640-4202
Fax—
Email—
Websitehttps://www.neurostar.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001227636
Description

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Additional info from NASDAQ:
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

2026-08-19 18:13

📋 MACAN WILLIAM ANDREW (Ex-Officer) plans to sell 150K shares of Neuronetics, Inc. (at $3.10 each, total $464K) Filed: Aug 19, 2026 | ID: 006219

Read more
2026-08-18 20:46

📋 MACAN WILLIAM ANDREW (Officer) plans to sell 121K shares of Neuronetics, Inc. (at $3.21 each, total $388K) Filed: Aug 18, 2026 | ID: 006183

Read more
2026-08-17 20:10

(99% Neutral) NEURONETICS, INC. (STIM) Announces New Board Appointment

Read more
2026-08-17 14:13

Chernett Jorey 🟡 adjusted position in 4.0K shares (1 derivative) of Neuronetics, Inc. (STIM) at $5.00 Transaction Date: Aug 13, 2026 | Filing ID: 002204

Read more
2026-08-11 18:28

New Form S-8 - Neuronetics, Inc. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001193125-26-345051 <b>Size:</b> 267 KB

Read more
2026-08-11 12:05

(30% Negative) NEURONETICS, INC. (STIM) Reports Q3 2026 Financial Results

Read more
2026-08-11 11:50

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Read more
2026-08-03 12:00

Neuronetics and Jorey Chernett Announce Shared Vision

Read more
2026-07-31 21:00

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more
2026-07-28 12:32

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

Read more